135 related articles for article (PubMed ID: 4373393)
1. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
Youngner JS; Keleti G; Feingold DS
Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
[TBL] [Abstract][Full Text] [Related]
2. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
Youngner JS; Feingold DS; Keleti G
Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of Brucella abortus preparations; separation of active components.
Feingold DS; Keleti G; Youngner JS
Infect Immun; 1976 Mar; 13(3):763-7. PubMed ID: 818014
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a Brucella abortus preparation.
Keleti G; Feingold DS; Youngner JS
Infect Immun; 1977 Mar; 15(3):846-9. PubMed ID: 404249
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.
Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
Infect Immun; 1979 Jan; 23(1):19-26. PubMed ID: 106004
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
[TBL] [Abstract][Full Text] [Related]
7. Induction of interferon by bacterial vaccines and allergenic extracts.
Singer SH; Hardegree MC; Duffin N; Ford M
J Allergy; 1971 Jun; 47(6):332-40. PubMed ID: 4325036
[No Abstract] [Full Text] [Related]
8. Interferon induction in mice by lipopolysaccharide from Brucella abortus.
Keleti G; Feingold DS; Youngner JS
Infect Immun; 1974 Jul; 10(1):282-3. PubMed ID: 4210341
[TBL] [Abstract][Full Text] [Related]
9. Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.
De Clercq E; De Somer P
Infect Immun; 1973 Oct; 8(4):669-73. PubMed ID: 4355140
[TBL] [Abstract][Full Text] [Related]
10. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of natural killer cell activity in mice by Bru-Pel.
Yabu K; Youngner JS; Feingold DS; Keleti G; Gorelik E
J Immunother (1991); 1991 Oct; 10(5):307-12. PubMed ID: 1790138
[TBL] [Abstract][Full Text] [Related]
12. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of resistance to virus challenge in mice infected with Brucella abortus.
Muyembe JJ; Billiau A; De Somer P
Arch Gesamte Virusforsch; 1972; 38(4):290-6. PubMed ID: 4343370
[No Abstract] [Full Text] [Related]
14. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
[TBL] [Abstract][Full Text] [Related]
15. Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.
Fultz PN; Shadduck JA; Kang CY; Streilein JW
Infect Immun; 1982 Aug; 37(2):679-86. PubMed ID: 6180986
[TBL] [Abstract][Full Text] [Related]
16. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
[TBL] [Abstract][Full Text] [Related]
17. Induction of the interferon system by various inducers.
Buckler CE; Wong KT; Baron S
Proc Soc Exp Biol Med; 1968 Apr; 127(4):1258-62. PubMed ID: 4297700
[No Abstract] [Full Text] [Related]
18. Development of tissue viral resistance in chickens following administration of interferon inducers.
Finkelstein MS
J Immunol; 1972 Jun; 108(6):1506-16. PubMed ID: 4337965
[No Abstract] [Full Text] [Related]
19. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.
Stringfellow DA; Glasgow LA
Infect Immun; 1972 Nov; 6(5):743-7. PubMed ID: 4344367
[TBL] [Abstract][Full Text] [Related]
20. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
